课题基金 / 基金详情

EFFECTS OF TIAGABINE/GABITRIL ON GROWTH HORMONE AND SLEEP IN OLDER PERSONS

EFFECTS OF TIAGABINE/GABITRIL ON GROWTH HORMONE AND SLEEP IN OLDER PERSONS
替加宾/加比曲对老年人生长激素和睡眠的影响
批准号:
7719342
负责人:
ORFEU M BUXTON
金额:
$0.89万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2008-05-31

项目摘要

项目成果

ORFEU M BUXTON的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的目的是检查一种名为替加宾(又称加比妥)的药物及其对睡眠中生长激素释放的影响。替加宾是美国FDA批准的一种帮助控制癫痫发作的药物。FDA还没有批准替加宾作为安眠药。这是一项由调查人员发起的研究。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to examine a drug called Tiagabine (also known as Gabitril) and its effect on the release of growth hormone during sleep. Tiagabine is a drug that is approved by the U.S. FDA to help control seizures. The FDA has not approved tiagabine as a sleep drug. This is an investigator initiated study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating Sleep-Related Disparities in U.S. Childrens Learning Difficulties
Investigating Sleep-Related Disparities in U.S. Childrens Learning Difficulties
Application of ambulatory methods for assessing short- and long-term associations of sleep health with cognitive decline in older adults
Application of ambulatory methods for assessing short- and long-term associations of sleep health with cognitive decline in older adults
海外基金